The Latin America, Middle East and Africa Nephrology and Urology Devices Market would witness market growth of 8.2% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 12,482.5 thousand units, showcasing a growth of 9.3% (2023-2030).
Sedentary lifestyles have contributed to a high incidence of chronic kidney and urinary disorders in nation. Furthermore, a rise in consumer awareness regarding minimally invasive procedures and an increased number of patients undergoing surgery contribute to the sector's expansion in these regions. Furthermore, an increase in awareness about the importance of early diagnosis & treatment of kidney and urology disorders has led to higher demand for screening & diagnostic devices, which further drive the nephrology devices market growth.
However, the high cost of urology devices is a significant factor that negatively impacts market growth, particularly in price-sensitive regions. The high cost of urology endoscopes and endovision systems may hamper market growth. In addition, the lack of skilled experts to operate & maintain urology devices are a significant factor that may restrain market growth. The lack of trained professionals can limit the utilization of these devices. On the other hand, the increase in demand for home-based dialysis solutions and portable devices that patients may efficiently operate provides a lucrative opportunity for the growth of the market growth of nephrology and urology devices.
As countries in the LAMEA region continue to develop and strengthen their healthcare infrastructure, there is a growing capacity for advanced medical devices, including those in nephrology and urology. Adopting telemedicine and digital health solutions in some parts of the LAMEA region may further support the use of nephrology and urology devices, especially for remote patient monitoring and consultation. Thus, the above aspects will expand the market growth across the region in the upcoming years.
The Brazil market dominated the LAMEA Nephrology and Urology Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $170 million by 2030. The Argentina market is showcasing a CAGR of 8.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.8% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. Based on Application, the market is segmented into Kidney Diseases, Bladder Disorders, Urolithiasis, Urological Cancer & BPH, and Others. Based on Product, the market is segmented into Urology Guidewires, Stone Basket, Renal Dilators, Mesh & Inserts, Ureteral Catheters, Urinary Stents, PCN Catheters, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Nephrology And Urology Devices Market is Projected to reach USD 8.5 Billion by 2030, at a CAGR of 6.3%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Hollister, Inc., Medtronic PLC, Coloplast Group, Boston Scientific Corporation, ConvaTec Group PLC, Baxter International, Inc., Asahi Kasei Corporation, Cook Medical, Inc. (Cook Group), Terumo Corporation, Teleflex Incorporated
By End-use (Volume, Thousand Units, USD Billion, 2019-2030)
By Application (Volume, Thousand Units, USD Billion, 2019-2030)
By Product (Volume, Thousand Units, USD Billion, 2019-2030)
By Country (Volume, Thousand Units, USD Billion, 2019-2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
